AU6506199A - Bone marrow-derived serum proteins - Google Patents

Bone marrow-derived serum proteins

Info

Publication number
AU6506199A
AU6506199A AU65061/99A AU6506199A AU6506199A AU 6506199 A AU6506199 A AU 6506199A AU 65061/99 A AU65061/99 A AU 65061/99A AU 6506199 A AU6506199 A AU 6506199A AU 6506199 A AU6506199 A AU 6506199A
Authority
AU
Australia
Prior art keywords
bone marrow
serum proteins
derived serum
derived
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65061/99A
Other languages
English (en)
Inventor
Neil C. Corley
Karl J Guegler
Dyung Aina M. Lu
Y. Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU6506199A publication Critical patent/AU6506199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU65061/99A 1998-10-02 1999-10-01 Bone marrow-derived serum proteins Abandoned AU6506199A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
USNOTGIVEN 1990-08-27
US16562198A 1998-10-02 1998-10-02
US09165621 1998-10-02
PCT/US1999/022908 WO2000020588A2 (fr) 1998-10-02 1999-10-01 Proteines seriques derivees de la moelle osseuse

Publications (1)

Publication Number Publication Date
AU6506199A true AU6506199A (en) 2000-04-26

Family

ID=22599695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65061/99A Abandoned AU6506199A (en) 1998-10-02 1999-10-01 Bone marrow-derived serum proteins

Country Status (2)

Country Link
AU (1) AU6506199A (fr)
WO (1) WO2000020588A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060292563A1 (en) * 2002-06-05 2006-12-28 Metabolex, Inc. Methods of diagnosing & treating diabetes and insulin resistance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするdna

Also Published As

Publication number Publication date
WO2000020588A3 (fr) 2000-07-06
WO2000020588A2 (fr) 2000-04-13

Similar Documents

Publication Publication Date Title
AU2434199A (en) Protein
AU4989399A (en) Bone morphogenic protein
AU2373800A (en) Neuron-associated proteins
AU3549499A (en) Telomerase-associated proteins
AU3185899A (en) Human calcium-binding proteins
HK1039158A1 (zh) Nlk1相互作用蛋白
AU4202699A (en) Human socs proteins
AU4073600A (en) Bone morphogenic proteins
AU3768199A (en) Human protease associated proteins
IL143052A0 (en) Mammalian chondromodulin-like protein
AU1957299A (en) Presenilin protein interactions
AU6000698A (en) Proteins
AU2659600A (en) Adipose specific protein
GB9816337D0 (en) Proteins
GB9828704D0 (en) Proteins
AU6506199A (en) Bone marrow-derived serum proteins
AU2593199A (en) Human smn-like protein
AU4992099A (en) Human presenilin-associated protein
AU2390800A (en) Secreted proteins
AU2659799A (en) Human receptor proteins
AU4766399A (en) Sara proteins
AU4438599A (en) Human arf-related proteins
AU2964700A (en) Bone marrow-specific protein
AU6058299A (en) Human chaperone proteins
AU6522199A (en) Secreted protein zsig49

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase